RecruitingAccepts healthy volunteers
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
M.D. Anderson Cancer Center · with Cancer Prevention Research Institute of Texas · NCT07010315
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- May 1, 2025
- Record last updated
- August 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To develop and test liver cancer prevention educational material.
Being studied: Cognitive Testing; Usability Testing
Conditions: Liver Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- At least 18 years old
- Participants at the HOPE Clinic
- Able to speak and read either English or Spanish
- For usability testing: Able to use and navigate websites on own smart phone or study computer
Exclusion Criteria
- Has been diagnosed with liver cancer
- Cannot provide consent or otherwise participate in research activities (e.g. vision or hearing impairment)
Recruiting US locations
MD Anderson Cancer Center
Houston, TX 77030
Site contact: Jessica Hwang, MD, MPH · 346-720-7352 · jphwang@mdanderson.org
Study contacts (from the official record)
- Jessica Hwang, MD, MPH · (346) 720-7352 · jphwang@mdanderson.org
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75